surmount-1 tirzepatide weight loss nondiabetic trial non-diabetic Tirzepatide for Obesity: Highlights from the SURMOUNT-1 Weight reduction over time in
Description
PeptideStack does not provide medical advice consult a qualified healthcare professional for treatment decisions
With GLP-1 ID, we're able to tailor the dose week by week based on how the patient is actually feeling and progressing
Chemical & physical profile Sequence: Y-Aib-EGTFTSDYSI-Aib-LDKIAQKAFVQWLIAGGPSSGAPPPS modified with Glu-2xOEG-C20 di-acid at K20 Molecular formula: C 225 H 348 N 48 O 68 Molecular weight: 4,813.45 g/mol CAS number: 2023788-19-2 Mechanism: Dual GIP and GLP-1 receptor agonist Appearance: White to off-white lyophilized powder Purity (HPLC): 99% Storage: 20C lyophilized (24 months)
Retrieved from Nguyen, S., Kaufman, M., Shetty, M., et al
GLP-1 medications solve this by using modified versions of the hormone that resist enzymatic breakdown, maintaining elevated levels for days or even a full week depending on the formulation
